Innovative deep proteomic profiling reveals promising results from a blood-based test for early breast cancer, showcasing ...

In the past decade there has been significant interest in studying the expression of our genetic code down to the level of single cells, to identify the functions and activities of any cell through ...

A new tool developed by Helmholtz Munich and the German Center for Diabetes Research and the University of Bonn makes spatial ...

Collaboration leverages OBT's proprietary OGAP®-Verify platform and GSK's drug development expertise to advance multiple selected novel oncology ...

A new tool developed by Helmholtz Munich and the German Center for Diabetes Research and the University of Bonn makes spatial ...

Imec has achieved the first successful wafer-scale fabrication of solid-state nanopores using EUV lithography on 300mm wafers ...

A 4.1% increase in military cyber funding in the FY2026 NDAA budget underpins new requirements for hardened mobile devices, AI security frameworks, and expanded DoD cyber workforce authorities.

Julio Aguirre-Ghiso, PhD, Rose C. Falkenstein Chair in Cancer Research, Professor of Cell Biology and Founding Director of the Cancer Dormancy Institute at Albert Einstein's Montefiore Einstein ...

Proteomics offers a significant opportunity to redefine disease diagnostics, potentially overtaking genomic assays. With double-digit growth and strong venture capital interest, the technology is ...

The discovery, featured on the cover of Analytical Chemistry, could potentially slow the progression to full-blown diabetes.

In this GEN webinar, our expert speakers will explore cutting-edge drug discovery techniques for target deconvolution and multiplex target discovery.

The University of Arkansas for Medical Sciences has been awarded a five-year, $10.5 million federal grant to develop biomarkers for human diseases, including cancer, university officials announced ...